Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes
- 26 January 2005
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (4), 1113-1118
- https://doi.org/10.1016/j.bbrc.2005.01.069
Abstract
No abstract availableKeywords
Funding Information
- Université de la Méditerranée
This publication has 30 references indexed in Scilit:
- Imipenem and expression of multidrug efflux pump in Enterobacter aerogenesBiochemical and Biophysical Research Communications, 2003
- The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenesAntimicrobial Agents and Chemotherapy, 2002
- Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year PeriodJournal of Clinical Microbiology, 2002
- mar Operon Involved in Multidrug Resistance of Enterobacter aerogenesAntimicrobial Agents and Chemotherapy, 2002
- National Epidemiologic Surveys of Enterobacter aerogenes in Belgian Hospitals from 1996 to 1998Journal of Clinical Microbiology, 2001
- Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenesMicrobiology, 1998
- Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutantsAntimicrobial Agents and Chemotherapy, 1994
- Carbapenem Resistance in Enterobacter aerogenes is due to Lipopolysaccharide AlterationsChemotherapy, 1991
- Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenesJournal of Antimicrobial Chemotherapy, 1990
- Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reductionAntimicrobial Agents and Chemotherapy, 1989